Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Azithromycin + Probiotics in Mild to Moderate Acne Vulgaris
NCT07384793Phase 4Active, not recruiting
- Sponsor
- Hayatabad Medical Complex
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 4 trial in acne vulgaris (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Reduction of Acne Lesion Count at 12 weeks. Started Oct 2025; status: active, not recruiting.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07384793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384793.